Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled Multicenter Trial on the Efficacy of Varenicline and Bupropion in Combination and Alone, for Treatment of Alcohol Use Disorder

NCT04167306 is registered in ClinicalTrials.gov with Vastra Gotaland Region as lead sponsor.

NCT NCT04167306
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04167306 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled Multicenter Trial on the Efficacy of Varenicline and Bupropion in Combination and Alone, for Treatment of Alcohol Use Disorder
Lead sponsor
Vastra Gotaland Region
Phase
Phase 2
Overall status
Completed
Start date
March 4, 2019
Completion date
December 15, 2022
Enrollment
388 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol dependence, alcohol use disorder, alcoholism